Viridian Therapeutics partners with Kissei Pharmaceutical to advance treatments for thyroid eye disease in Japan, enhancing patient care and market potential.

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...

Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking ...

Psyence Biomedical Ltd. (Nasdaq: PBM) ('Psyence BioMed” or the 'Company”) is pleased to announce that its strategic partner, PsyLabs - a leader in the production of purified psychedelic compounds - ...

This acquisition enables ESTEVE to expand its contract development and manufacturing services for small-molecule active pharmaceutical ingredients from pre-clinical to commercial manufacturing in the ...

Sanofi Q2 sales rose 10.1% at constant currency, led by Dupixent and ALTUVIIIO. EPS missed estimates; 2025 sales guidance was revised upward.

The pharmaceutical industry is undergoing a transformative shift fueled by data analytics. As drug development becomes increasingly complex, analytics is emerging as a key enabler of innovation and ...

July 7 – With a 90-day negotiating period on country-specific US tariffs is set to expire on July 9, Trump enacts a multitude ...

Melbourne-based biotech VC Boson Ventures has raised $10 million of a target $30 million fund and is positioning itself as a ...

Trump demanded that pharmaceutical companies lower their drug prices. But it's unclear how the government may enforce the ...

B vitamins are water-soluble nutrients that are essential for countless bodily processes. Certain conditions, such as ...

Employed biopharma professionals are highly likely to look for new jobs in the next 12 months, although not quite as likely ...